From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

RAISE: Collecting Better Data: Incentives, Framework, and Mission
RAISE: Collecting Better Data: Incentives, Framework, and Mission Thursday, February 2, 2023 2-3 PM ET   Incomplet
Real-World Accelerator to Improve the Standard of collection and curation of race and Ethnicity data in healthcare (RAISE)
Improving the Collection and Curation of Race and Ethnicity Data in Health Care Thursday, January 26, 2023 2-4 PM ET 
2022 Innovations in Regulatory Science Awards
COVID-19 Evidence Accelerator: What We've Learned, Where We're Headed
In the midst of a global pandemic, the Reagan-Udall Foundation for the FDA, along with Friends of Cancer Research, created an unprecedented regulatory science collaborative to share real-world data and to generate
Public Meeting of the Independent Expert Panel - FDA Human Foods Program
Join us to observe the in-person public meeting of the Food Independent Expert Panel on September 29 & 30.
Therapeutics and Vaccines Lab Meeting
Eric Young of TriNetX will take us through the characterization of breakthrough infections for vaccinated individuals, including children, who received both outpatient and inpatient treatment.
Diagnostics Lab Meeting
 Professor Mara Aspinall of the Diagnostic Commons housed at Arizona State University will join us to reflect on the past, present and future of diagnostic tests. Matthew Gee of Siemens will take a look at lessons learned
Therapeutics/Vaccines Lab Meeting
Join us Thursday, July 21 at 3 pm ET for the July Therapeutics & Vaccines lab Meeting. We’ll be hearing from Elizabeth Eldridge of Health Catalyst.
Diagnostics Lab Meeting
Join us Thursday, July 21 at noon ET to hear from Dr. Keith Campbell of FDA's Center for Devices and Radiological Health.
Therapeutics/Vaccines Lab Meeting
Beyond the learning acceleration of our COVID-19 Evidence Accelerator lab meetings, the Evidence Accelerator model includes “engines” of evidence generation.